Comment on Lee et al. Sodium –Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study. Diabetes Care 2021;44:2419–2426

We read with great interest the article by Lee et al. (1) showing an increased risk of retinal vein occlusion (RVO) among patients with diabetes initiating sodium –glucose cotransporter 2 inhibitors (SGLT2i) based on a very large Korean cohort.
Source: Diabetes Care - Category: Endocrinology Source Type: research